Nomura Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.97M Sell
5,400
-9,900
-65% -$10M 0.01% 639
2025
Q4
$16.4M Buy
15,300
+4,500
+42% +$4.3M 0.02% 368
2025
Q3
$8.24M Sell
10,800
-17,400
-62% -$12.9M 0.01% 583
2025
Q2
$22M Buy
28,200
+11,200
+66% +$8.7M 0.05% 236
2025
Q1
$14M Buy
+17,000
New +$14.1M 0.03% 379
2023
Q3
Sell
-50,000
Closed -$23.4M 1519
2023
Q2
$23.4M Buy
+50,000
New +$21M 0.06% 194
2019
Q2
Sell
-665,000
Closed -$85.8M 1240
2019
Q1
$85.8M Buy
+665,000
New +$80.9M 0.36% 48
2018
Q2
Sell
-48,134
Closed -$3.72K 1440
2018
Q1
$3.72K Sell
48,134
-21,466
-31% -$1.73M 0.01% 644
2017
Q4
$5.88M Buy
69,600
+46,900
+207% +$3.99M 0.01% 578
2017
Q3
$1.94M Hold
22,700
﹤0.01% 859
2017
Q2
$1.87M Hold
22,700
﹤0.01% 857
2017
Q1
$1.91M Buy
+22,700
New +$1.82M 0.01% 679
2015
Q1
Sell
-106,400
Closed -$7.27M 2050
2014
Q4
$7.27M Sell
106,400
-14,600
-12% -$985K 0.02% 468
2014
Q3
$7.81M Buy
121,000
+32,800
+37% +$2.08M 0.02% 519
2014
Q2
$5.47M Sell
88,200
-51,800
-37% -$3.09M ﹤0.01% 642
2014
Q1
$8.22M Buy
+140,000
New +$7.81M ﹤0.01% 546

Other funds holding LLY

Nomura Holdings's LLY Position: Q1 2026 in Review

Nomura Holdings increased its Eli Lilly (LLY) stake by 167% in Q1 2026, buying an estimated $11M and bringing the position to 17,421 shares worth $16M. The position accounts for 0.04% of the portfolio, ranked #307.

Nomura Holdings first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $85.8M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Nomura Holdings held 17,421 shares of Eli Lilly worth $16M as of Q1 2026.
  • Nomura Holdings bought 10,885 Eli Lilly shares in Q1 2026, an estimated $11M.
  • Eli Lilly made up 0.04% of Nomura Holdings's portfolio in Q1 2026, its #307 holding.
  • Nomura Holdings first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
  • Nomura Holdings's Eli Lilly position peaked at $85.8M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.